Adjunct Instructor
Division of Gynecologic Oncology
Contact Information
| Mailing Address: |
Division of Gynecologic Oncology |
| Academic Phone: | 415-885-5761 / 415-885-7204 |
| Academic Fax: | 415-885-3586 |
| Department: | Obstetrics, Gynecology & Reproductive Sciences |
Research/Clinical Interests
Dr. Stephanie Cham’s primary research focus is to reduce disparities and improve perioperative care for gynecologic cancer patients, particularly in vulnerable populations, through innovative healthcare services outcomes research and the development of novel and scalable interventions including those leveraging new care delivery approaches and technology.
Dr. Stephanie Cham joins the faculty practice as a National Institute of Health Women’s Reproductive Health Research scholar, with a focus on how we can optimize cancer care delivery, particularly in frail and elderly patients. Her prior work has been presented at national conferences and published in journals including JAMA Oncology, American Journal of Obstetrics and Gynecology, Gynecologic Oncology, JAMA Network Open, and Obstetrics and Gynecology. Her clinical interests include providing exceptional and high-quality surgical care to patients as well as teaching trainees.
Education/Training
| Year | Institution & Location | Degree | Field of Study |
|---|---|---|---|
|
2010 |
University of California San Diego, La Jolla, CA |
B.S. |
Human Biology |
|
2015 |
University of California Los Angeles, David Geffen School of Medicine, Los Angeles, CA |
M.D. |
Medicine |
|
2019 |
Columbia University Medical Center, New York NY |
Residency |
Obstetrics and Gynecology |
|
2022 |
Brigham and Women’s Hospital/Dana-Farber Cancer Center, Boston, MA |
Fellowship |
Gynecologic Oncology |
Achievements & Recognition
| Year | Major Honors |
|---|---|
|
2014 |
Alpha Omega Alpha, UCLA |
|
2015 |
American Medical Women’s Association Certificate of Commendation, UCLA |
|
2017 |
Excellence in Teaching Award, Columbia University |
|
2019 |
Society of Gynecologic Oncology Outstanding Resident Award |
|
2020 |
Foundation for Women’s Cancer Laura Crandall Brown Ovarian Cancer Early Detection Grant |
|
2022 |
American Society of Clinical Oncology Young Investigator Award in Ovarian Cancer |
Selected Recent Publications
Cham S, Landrum MB, Keating NL, Armstrong J, Wright AA. Use of Germline BRCA Testing in Patients With Ovarian Cancer and Commercial Insurance. JAMA Netw Open. 2022 Jan 4;5(1):e2142703. doi: 10.1001/jamanetworkopen.2021.42703. PMID: 35015069; PMCID: PMC8753497.
Cham S, Li A, Rauh-Hain JA, Tergas AI, Hershman DL, Wright JD, Melamed A. Association Between Neighborhood Socioeconomic Inequality and Cervical Cancer Incidence Rates in New York City. JAMA Oncol. 2021 Nov 24. doi: 10.1001/jamaoncol.2021.5779. Epub ahead of print. PMID: 34817550.
Cham S, Huang Y, Melamed A, Worley MJ Jr, Hou JY, Tergas AI, Khoury-Collado F, Gockley A, Clair CMST, Hershman DL, Wright JD. Fragmentation of surgery and chemotherapy in the initial phase of ovarian cancer care and its association with overall survival. Gynecol Oncol. 2021 Jul;162(1):56-64. doi: 10.1016/j.ygyno.2021.04.032. Epub 2021 May 6. PubMed PMID: 33965245.
Sia TY, Wen T, Cham S, Friedman AM, Wright JD. Effect of frailty on postoperative readmissions and cost of care for ovarian cancer. Gynecol Oncol. 2020 Nov;159(2):426-433. doi: 10.1016/j.ygyno.2020.08.024. Epub 2020 Aug 28. PubMed PMID: 32868087.
Cham S, Wen T, Friedman A, Wright JD. Fragmentation of postoperative care after surgical management of ovarian cancer at 30-days and 90-days. Am J Obstet Gynecol. 2019 Sep 11;. doi: 10.1016/j.ajog.2019.09.005. [Epub ahead of print] PubMed PMID: 31520627.
Cham S, Chen L, St Clair CM, Hou JY, Tergas AI, Melamed A, Ananth CV, Neugut AI, Hershman DL, Wright JD. Development and validation of a risk-calculator for adverse perioperative outcomes for women with ovarian cancer. Am J Obstet Gynecol. 2019 Jun;220(6):571.e1-571.e8. doi: 10.1016/j.ajog.2019.02.019. Epub 2019 Feb 13. PubMed PMID: 30771346